ALA-PDT for the treatment of cutaneous pseudolymphoma: a case report.

Cutaneous pseudolymphoma (CPL) is a benign skin condition that may cause cosmetic disfigurement, severe itch and, albeit rarely, transformation to malignant lymphoma. The usual treatment modalities for CPL have been associated with adverse effects including skin atrophy and scarring. This article reports the case of a patient with CPL on the cheek, which was treated with 5-aminolevulinic acid photodynamic therapy (ALA-PDT). Clinically significant improvement in lesion size and symptoms was noted, with few side effects. Controlled trials and long-term monitoring are warranted to further explore this treatment modality for CPL.
AuthorsJenna O'Neill, Sari Fien, Nathalie C Zeitouni
JournalJournal of drugs in dermatology : JDD (J Drugs Dermatol) Vol. 9 Issue 6 Pg. 688-9 (Jun 2010) ISSN: 1545-9616 [Print] United States
PMID20645532 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Photosensitizing Agents
  • Aminolevulinic Acid
  • Aminolevulinic Acid (administration & dosage, adverse effects)
  • Humans
  • Male
  • Middle Aged
  • Photochemotherapy
  • Photosensitizing Agents (administration & dosage)
  • Pseudolymphoma (drug therapy)
  • Skin Diseases (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: